1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)
    Meeting Abstract

    Alsina, M.; Tabernero, J.; Shitara, K.; Doi, T.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Ghidini, M.; Faustino, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neutrophil to lymphocyte ratio ≥4 correlates with 6-month postoperative mortality in cancer patients age >75
    Meeting Abstract

    Ali, I. Y.; Sarraf, S.; Downey, R. J.; Kim, S. J.; Alexander, K.; Korc-Grodzicki, B.; Shahrokni, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Benefit of early-phase targeted, basket, and immune-based trials for patients with chemorefractory gastrointestinal (GI) cancers
    Meeting Abstract

    Agarwal, R.; Cangemi, N. A.; Epstein, A. S.; Harding, J. J.; Segal, N. H.; Reidy, D. L.; Hyman, D. M.; Saltz, L. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial
    Meeting Abstract

    Abou-Alfa, G. K.; Meyer, T.; Cheng, A. L.; Cicin, I.; Bolondi, L.; Klümpen, H. J.; Chan, S. L.; Dadduzio, V.; Milwee, S.; Dubey, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ia/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): Interim safety, efficacy, and pharmacokinetic findings in advanced cancers
    Meeting Abstract

    Harding, J. J.; Patnaik, A.; Moreno, V.; Stein, M.; Jankowska, A. M.; de Mendizabal, N. V.; Liu, Z. T.; Koneru, M.; Calvo, E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CB-839, a glutaminase inhibitor, in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer (mRCC): Results of a phase I study
    Meeting Abstract

    Meric-Bernstam, F.; Lee, R. J.; Carthon, B. C.; Iliopoulos, O.; Mier, J. W.; Patel, M. R.; Tannir, N. M.; Owonikoko, T. K.; Haas, N. B.; Voss, M. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes after cessation of therapy with alkylating agents (AA) for pancreatic neuroendocrine tumors (panNETs)
    Meeting Abstract

    Wu, L.; Reidy, D. L.; Bielska, A.; Kelly, V.; Raj, N. P.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of cabiralizumab (cabira) + nivolumab (vivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Wang-Gillam, A.; O'Reilly, E. M.; Bendell, J. C.; Wainberg, Z. A.; Borazanci, E. H.; Bahary, N.; O'Hara, M. H.; Beatty, G. L.; Pant, S.; Cohen, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • T-cell inflamed gene expression profile (GEP) and PD-Li expression in patients (pts) with esophageal cancer (EC)
    Meeting Abstract

    Steiniche, T.; Rha, S. Y.; Chung, H. C.; Georgsen, J. B.; Ladekarl, M.; Nordsmark, M.; Jespersen, M. L.; Kim, H. S.; Kim, H.; Fein, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Halo 110-101: Early safety results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + cisplatin (C) + gemcitabine (G) ± atezolizumab (ATZ) in patients (pts) with locally advanced or metastatic cholangiocarcinoma (CCA) and gallbladder cancer (GBC)
    Meeting Abstract

    Oh, D. Y.; Muhsin, M.; Bullock, A. J.; Abou-Alfa, G. K.; Shroff, R. T.; Sigal, D.; Chung, V.; Hecht, J. R.; Wu, W.; Borad, M. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save